Company / Current Assets
NovaBay Pharmaceuticals, Inc. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.9M
FY2024
5-year range
$1.9M / $14.2M
FY2020-FY2024
Trend
-73.0%
vs FY2023
Sector context
#214 of 215
Health Care
What the data says
Among 215 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 0% for current assets. Current Assets has declined for 4 consecutive years, from $14M in FY2020 to $2M in FY2024.
Based on SEC 10-K filings.
$2M in FY2024 with a 5-year CAGR of -27.1%.
Declined from $11M to $2M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -47.2%
- 5-Year CAGR
- -27.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 215This company $1.9M Sector average $2.5B
▼
-99.9% below sector average
Key checks
Key Insights
- NovaBay Pharmaceuticals, Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -27.1%, indicating a declining trend.
- In FY2024, current assets decreased 73.0% year-over-year.
- Ranks #214 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.9M | -73.0% |
| FY2023 | $7.2M | -36.9% |
| FY2022 | $11.3M | -14.0% |
| FY2021 | $13.2M | -7.5% |
| FY2020 | $14.2M | +51.8% |
| FY2019 | $9.4M | +9.0% |
| FY2018 | $8.6M | -4.3% |
| FY2017 | $9.0M | -37.8% |
| FY2016 | $14.5M | +219.7% |
| FY2015 | $4.5M | -34.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026